{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:40:08Z","timestamp":1750005608938,"version":"3.41.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Infants with inborn errors of immunity (IEI), born in countries where Bacillus-Calmette-Guerin (BCG) vaccination is recommended at birth, are at risk of developing infectious complications following vaccination. A prompt diagnosis of disseminated BCG infection in these infants is essential, as many will require stem cell transplantation (SCT) for the immunologic cure. In patients with IEI, the mortality risk from disseminated mycobacterial infection is high, both before and following SCT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A 7-month-old Qatari infant with an IEI, homozygous <jats:italic toggle=\"yes\">IKBKB<\/jats:italic> gene mutation, was evaluated at our institution for SCT. He had a history of recurrent pneumonias, but pretransplant evaluation revealed negative cultures from bronchoalveolar fluid, blood and urine. At 8 months of age, the infant developed skin nodules of unclear etiology, prompting additional evaluation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Given his profound immunosuppression and receipt of broad-spectrum antimicrobials, plasma metagenomic next-generation sequencing (mNGS) was obtained and identified <jats:italic toggle=\"yes\">Mycobacterium tuberculosis complex<\/jats:italic> within 72 hours. A skin biopsy was performed, and antimycobacterial therapy was initiated. <jats:italic toggle=\"yes\">Mycobacterium bovis-BCG<\/jats:italic> was confirmed from cultures 3 weeks later. Treatment was complicated by elevated serum liver transaminases and aminoglycoside-associated high-frequency hearing loss. The infant completed 14 months of treatment from engraftment. Evaluation for active BCG infection after SCT was negative.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>In an infant with a unique IEI, plasma mNGS provided the first diagnosis of disseminated BCG infection. We believe that early initiation of antimycobacterial treatment improved the infant\u2019s clinical outcome. Plasma mNGS testing should be considered as a noninvasive screen for infectious pathogens in children with IEIs before SCT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003465","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T10:00:34Z","timestamp":1643018434000},"page":"430-435","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Plasma Metagenomic Sequencing Expedites Diagnosis of Disseminated BCG in an Infant With IKBKB Mutation"],"prefix":"10.1097","volume":"41","author":[{"given":"Margaret G.","family":"Taylor","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Section of Infectious Diseases, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah K.","family":"Nicholas","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Immunology Allergy and Retrovirology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa R.","family":"Forbes Satter","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Immunology Allergy and Retrovirology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caridad","family":"Martinez","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay H.","family":"Cameron","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Infectious Diseases, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"R1-20250615","first-page":"73","article-title":"BCG vaccines: WHO position paper - February 2018.","volume":"93","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jinf.2012.03.012","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) complications associated with primary immunodeficiency diseases.","volume":"64","author":"Norouzi","year":"2012","journal-title":"J Infect"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13104-017-2499-7","article-title":"Disseminated Bacillus Calmette-Gu\u00e9rin (BCG) infections in infants with immunodeficiency.","volume":"10","author":"Al-Hammadi","year":"2017","journal-title":"BMC Res Notes"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jaci.2014.02.028","article-title":"BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies.","volume":"133","author":"Marciano","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMoa1309199","article-title":"Deficiency of innate and acquired immunity caused by an IKBKB mutation.","volume":"369","author":"Pannicke","year":"2013","journal-title":"N Engl J Med"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.clim.2018.10.019","article-title":"Clinical presentation, immunologic features, and hematopoietic stem cell transplant outcomes for IKBKB immune deficiency.","volume":"205","author":"Cuvelier","year":"2019","journal-title":"Clin Immunol"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2013.12.1093","article-title":"Immunodeficiency and disseminated mycobacterial infection associated with homozygous nonsense mutation of IKK\u03b2.","volume":"134","author":"Burns","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1007\/s10875-014-0097-1","article-title":"Immunodeficiency associated with a nonsense mutation of IKBKB.","volume":"34","author":"Nielsen","year":"2014","journal-title":"J Clin Immunol"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1182\/blood-2014-04-571265","article-title":"A nonsense mutation in IKBKB causes combined immunodeficiency.","volume":"124","author":"Mousallem","year":"2014","journal-title":"Blood"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"517544","DOI":"10.3389\/fimmu.2020.517544","article-title":"A novel homozygous mutation destabilizes IKK\u03b2 and leads to human combined immunodeficiency.","volume":"11","author":"Qin","year":"2020","journal-title":"Front Immunol"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1084\/jem.20060085","article-title":"X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production.","volume":"203","author":"Filipe-Santos","year":"2006","journal-title":"J Exp Med"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41564-018-0349-6","article-title":"Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease.","volume":"4","author":"Blauwkamp","year":"2019","journal-title":"Nat Microbiol"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"101548","DOI":"10.1016\/j.bjid.2021.101548","article-title":"Metagenomic next-generation sequencing (mNGS) for diagnostically challenging infectious diseases in patients with acute leukemia.","volume":"25","author":"Garnica","year":"2021","journal-title":"Braz J Infect Dis"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.diagmicrobio.2018.06.009","article-title":"Liquid biopsy for infectious diseases: sequencing of cell-free plasma to detect pathogen DNA in patients with invasive fungal disease.","volume":"92","author":"Hong","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.12688\/f1000research.19766.3","article-title":"Next-generation sequencing of microbial cell-free DNA for rapid noninvasive diagnosis of infectious diseases in immunocompromised hosts.","volume":"8","author":"Camargo","year":"2019","journal-title":"F1000Res"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"ofz327","DOI":"10.1093\/ofid\/ofz327","article-title":"Noninvasive diagnosis of infection using plasma next-generation sequencing: a single-center experience.","volume":"6","author":"Rossoff","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"e00794","DOI":"10.1128\/JCM.00794-20","article-title":"Plasma metagenomic next-generation sequencing assay for identifying pathogens: a retrospective review of test utilization in a large children\u2019s hospital.","volume":"58","author":"Niles","year":"2020","journal-title":"J Clin Microbiol"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"e1001012","DOI":"10.1371\/journal.pmed.1001012","article-title":"The BCG World Atlas: a database of global BCG vaccination policies and practices.","volume":"8","author":"Zwerling","year":"2011","journal-title":"PLoS Med"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tube.2009.03.002","article-title":"Mapping the global use of different BCG vaccine strains.","volume":"89","author":"Ritz","year":"2009","journal-title":"Tuberculosis (Edinb)"},{"key":"R20-20250615","doi-asserted-by":"crossref","first-page":"22758","DOI":"10.1074\/jbc.M113.482596","article-title":"Crystal structure of a human I\u03baB kinase \u03b2 asymmetric dimer.","volume":"288","author":"Liu","year":"2013","journal-title":"J Biol Chem"},{"key":"R21-20250615","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1128\/CMR.00001-11","article-title":"Infectious diseases in patients with IRAK-4, MyD88, NEMO, or I\u03baB\u03b1 deficiency.","volume":"24","author":"Picard","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jvscit.2018.11.006","article-title":"Rapid detection of bacille Calmette-Gu\u00e9rin-associated mycotic aortic aneurysm using novel cell-free DNA assay.","volume":"5","author":"Vudatha","year":"2019","journal-title":"J Vasc Surg Cases Innov Tech"},{"key":"R23-20250615","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/bmt.2015.146","article-title":"Successful management of cutaneous BCG dissemination in a child affected by SCID and receiving allogeneic hematopoietic stem cell transplant.","volume":"50","author":"Naselli","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"R24-20250615","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/tid.12263","article-title":"Disseminated Bacillus Calmette-Gu\u00e9rin (BCG) infection following allogeneic hematopoietic stem cell transplant in a patient with Bare Lymphocyte Syndrome type II.","volume":"16","author":"Abu-Arja","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"R25-20250615","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10875-020-00892-6","article-title":"Bacillus Calmette-Guerin (BCG) Vaccine-associated complications in immunodeficient patients following stem cell transplantation.","volume":"41","author":"NaserEddin","year":"2021","journal-title":"J Clin Immunol"},{"key":"R26-20250615","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1128\/AAC.01302-08","article-title":"Susceptibility of mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.","volume":"53","author":"Ritz","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R27-20250615","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.bbmt.2009.05.021","article-title":"Hematologic safety profile of linezolid in the early periengraftment period after allogeneic stem cell transplantation.","volume":"15","author":"Cohen","year":"2009","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003465","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:03:58Z","timestamp":1750003438000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003465","relation":{},"ISSN":["0891-3668"],"issn-type":[{"type":"print","value":"0891-3668"}],"subject":[],"published":{"date-parts":[[2022,1,20]]}}}